Poly Medicure · NSE: POLYMED · BSE: 531768
Q1 FY24 results · Apr–Jun 2023
Poly Medicure reported revenue from operations of ₹320.83 crore (up 28.9% from Q1 FY23) and net profit of ₹62.70 crore (up 132.5% from Q1 FY23) for Q1 FY24 (Apr–Jun 2023), on a consolidated basis.
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 320.83 | 248.85 | +28.9% | 306.85 | +4.6% |
| Other income | 13.11 | 4.57 | +186.9% | 8.49 | +54.4% |
| Total income | 333.94 | 253.42 | +31.8% | 315.35 | +5.9% |
| Profit before tax | 83.04 | 35.89 | +131.4% | 74.57 | +11.4% |
| Net profit for the period | 62.70 | 26.96 | +132.5% | 58.81 | +6.6% |
| EPS, basic (₹) | 6.54 | 2.81 | +132.7% | 6.13 | +6.7% |
| Net margin (%) | 19.5 | 10.8 | 19.2 |
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 305.56 | 239.01 | +27.8% | 293.31 | +4.2% |
| Other income | 13.17 | 4.58 | +187.7% | 8.66 | +52.1% |
| Total income | 318.73 | 243.58 | +30.8% | 301.97 | +5.6% |
| Profit before tax | 80.87 | 38.13 | +112.1% | 73.40 | +10.2% |
| Net profit for the period | 60.52 | 28.80 | +110.2% | 57.48 | +5.3% |
| EPS, basic (₹) | 6.31 | 3.00 | +110.3% | 6.00 | +5.2% |
| Net margin (%) | 19.8 | 12.0 | 19.6 |
Consolidated
- Filed with BSE
- 07 Aug 2023, 16:25 IST
- Board meeting
- 07 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Aug 2023, 16:25 IST
- Board meeting
- 07 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE